BR9807592A - Utilização do 9,10-secocolesta-5, 7, 10 (19) - trien-1, 3-ol ou alfacalcidol - Google Patents

Utilização do 9,10-secocolesta-5, 7, 10 (19) - trien-1, 3-ol ou alfacalcidol

Info

Publication number
BR9807592A
BR9807592A BR9807592-6A BR9807592A BR9807592A BR 9807592 A BR9807592 A BR 9807592A BR 9807592 A BR9807592 A BR 9807592A BR 9807592 A BR9807592 A BR 9807592A
Authority
BR
Brazil
Prior art keywords
secocolesta
alfacalcidol
trien
cancer
alfacacidol
Prior art date
Application number
BR9807592-6A
Other languages
English (en)
Inventor
Paul Trouillas
Original Assignee
Paul Trouquillas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Trouquillas filed Critical Paul Trouquillas
Publication of BR9807592A publication Critical patent/BR9807592A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"UTILIZAçãO DO 9,10-SECOCOLESTA-5,7,10 (19)-TRIEN-1,3-OL OU ALFACALCIDOL". A invenção refere-se à utilização do 9,10-secocolesta-5,7,10 (19)-trien-1,3-ol ou alfacalcidol para a fabricação de um medicamento destinado ao tratamento e/ou à prevenção dos cânceres sólidos dos seres humanos, especialmente o câncer do pulmão e os cânceres do encéfalo. A dose eficaz está compreendida entre 0,25 e 10 Ág / dia para um adulto de 60 kg.
BR9807592-6A 1997-02-20 1998-02-20 Utilização do 9,10-secocolesta-5, 7, 10 (19) - trien-1, 3-ol ou alfacalcidol BR9807592A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702247A FR2759586B1 (fr) 1997-02-20 1997-02-20 Medicament de type anticancereux comportant au moins a titre de principe actif du 1-alpha hydroxycalciferol ou alfacalcidol
PCT/FR1998/000347 WO1998036754A1 (fr) 1997-02-20 1998-02-20 Utilisation du 9,10-secocholesta-5,7,10(19)-trien-1,3-ol, ou alfacalcidol

Publications (1)

Publication Number Publication Date
BR9807592A true BR9807592A (pt) 2000-02-22

Family

ID=9504159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807592-6A BR9807592A (pt) 1997-02-20 1998-02-20 Utilização do 9,10-secocolesta-5, 7, 10 (19) - trien-1, 3-ol ou alfacalcidol

Country Status (15)

Country Link
EP (1) EP0981350B1 (pt)
JP (1) JP2001511818A (pt)
KR (1) KR20000075514A (pt)
CN (1) CN1248168A (pt)
AT (1) ATE206306T1 (pt)
AU (1) AU6505098A (pt)
BR (1) BR9807592A (pt)
CA (1) CA2282086A1 (pt)
DE (1) DE69801907D1 (pt)
FR (1) FR2759586B1 (pt)
IL (1) IL131502A0 (pt)
NO (1) NO993997L (pt)
PL (1) PL335190A1 (pt)
TR (1) TR199901998T2 (pt)
WO (1) WO1998036754A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004026811A (ja) * 2002-04-30 2004-01-29 Kiyoshi Hashizume ビタミンｄ３誘導体を含有する抗癌作用を増強させるための薬剤
GB201704909D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
IL110117A0 (en) * 1994-06-24 1994-10-07 Univ Ben Gurion Pharmaceutical compositions comprising vitamin-d analogs

Also Published As

Publication number Publication date
NO993997L (no) 1999-10-19
CN1248168A (zh) 2000-03-22
PL335190A1 (en) 2000-04-10
DE69801907D1 (de) 2001-11-08
EP0981350B1 (fr) 2001-10-04
KR20000075514A (ko) 2000-12-15
TR199901998T2 (xx) 1999-11-22
FR2759586B1 (fr) 2000-01-14
FR2759586A1 (fr) 1998-08-21
AU6505098A (en) 1998-09-09
JP2001511818A (ja) 2001-08-14
IL131502A0 (en) 2001-01-28
WO1998036754A1 (fr) 1998-08-27
CA2282086A1 (fr) 1998-08-27
NO993997D0 (no) 1999-08-19
EP0981350A1 (fr) 2000-03-01
ATE206306T1 (de) 2001-10-15

Similar Documents

Publication Publication Date Title
AP9801392A0 (en) Concentrated antibody preparation.
EP0671920A4 (en) AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES.
CS553490A3 (en) Transdermal therapeutic system
HK1032759A1 (en) Apparatus for restoring the balance of the human body.
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
EP0859637A4 (en) COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF WEIGHT PROBLEMS, INCLUDING OBESITY
HUP0105058A2 (hu) Perifériás benzodiazepin receptorhoz kötődő anyag alkalmazása kutánstressz kezelésére
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
TR200001203T2 (tr) Yeni birleşik maddeler
TR200001544T2 (tr) Yeni bileşikler.
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
DE59608213D1 (de) Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen
EP0744176A3 (en) Methods for inhibiting bone loss
BR9807592A (pt) Utilização do 9,10-secocolesta-5, 7, 10 (19) - trien-1, 3-ol ou alfacalcidol
NL300083I1 (nl) 1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen.
AU2379997A (en) Remedy for external application, and use of an oil-in-water emulsion for said remedy
GR3015462T3 (en) Dynamic redression splint for the therapy of the forefoot adduction.
IT240104Y1 (it) Dispositivo per il trattamento del corpo umano.
SE8704471D0 (sv) Solarium
WO1999060988A3 (en) Combination therapy for treatment of fiv infection
MY114109A (en) The use of bioassimilable boron compounds
AU6819898A (en) Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
GR950100315A (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]